T1	Concept 34 50	Zika NS2B-NS3pro
T2	Concept 54 65	susceptible
T3	Concept 69 90	allosteric inhibition
T4	Concept 24 30	pocket
R3	has-property Arg1:T1 Arg2:T4	
R1	has-property Arg1:T4 Arg2:T2	
R2	in-context Arg1:T4 Arg2:T3	
T5	Concept 109 114	small
T6	Concept 115 124	molecules
T7	Concept 128 137	different
T8	Concept 138 146	scaffols
R4	has-property Arg1:T6 Arg2:T5	
R5	in-context Arg1:T6 Arg2:T8	
R6	has-property Arg1:T8 Arg2:T7	
A1	Emphasized T6
R7	causes Arg1:T6 Arg2:T4	
T9	Action 151 171	empirical estimation
T10	Concept 213 221	COVID-19
T11	Concept 222 227	cases
R8	in-context Arg1:T11 Arg2:T10	
T12	Concept 197 202	newly
T13	Concept 172 177	based
T14	Concept 181 193	real numbers
R9	has-property Arg1:T9 Arg2:T13	
R10	in-context Arg1:T13 Arg2:T14	
R11	in-context Arg1:T13 Arg2:T11	
R12	has-property Arg1:T11 Arg2:T12	
T15	Concept 242 245	one
T16	Concept 246 249	new
T17	Action 250 259	infection
R13	has-property Arg1:T17 Arg2:T16	
R14	in-context Arg1:T17 Arg2:T15	
T18	Action 269 277	decrease
R15	causes Arg1:T17 Arg2:T18	
T19	Concept 292 295	new
T20	Concept 296 301	cases
R17	has-property Arg1:T20 Arg2:T19	
T21	Concept 282 288	number
R16	target Arg1:T18 Arg2:T21	
R18	has-property Arg1:T20 Arg2:T21	
T22	Concept 305 310	0.097
R19	in-context Arg1:T18 Arg2:T22	
T23	Concept 351 355	week
T24	Concept 326 335	following
T25	Concept 336 341	first
T26	Concept 312 317	0.438
T27	Concept 343 349	second
R20	is-a Arg1:T25 Arg2:T23	
R21	is-a Arg1:T27 Arg2:T23	
R22	has-property Arg1:T25 Arg2:T24	
R23	in-context Arg1:T22 Arg2:T25	
R24	in-context Arg1:T18 Arg2:T26	
R25	in-context Arg1:T26 Arg2:T27	
R26	has-property Arg1:T27 Arg2:T24	
T28	Concept 363 376	February 2-15
R27	entails Arg1:T9 Arg2:T17	
R28	in-context Arg1:T9 Arg2:T29	
T29	Concept 377 386	subsample
R29	in-time Arg1:T29 Arg2:T28	
T30	Concept 406 419	effectiveness
T31	Concept 423 430	China's
T32	Concept 431 442	large-scale
T33	Concept 443 453	quarantine
T34	Concept 454 460	policy
R30	in-place Arg1:T34 Arg2:T31	
R31	has-property Arg1:T34 Arg2:T32	
R32	has-property Arg1:T34 Arg2:T33	
R33	has-property Arg1:T34 Arg2:T30	
R34	entails Arg1:T9 Arg2:T30	
T35	Concept 480 487	genomes
T36	Concept 472 479	diploid
T37	Concept 465 471	normal
T38	Concept 489 493	wild
T39	Concept 494 501	strains
T41	Concept 514 517	lab
T42	Concept 518 525	strains
T43	Concept 528 542	heterozygosity
T44	Concept 546 557	not uniform
T45	Concept 565 568	276
T46	Concept 573 579	genome
R35	has-property Arg1:T35 Arg2:T36	
R36	has-property Arg1:T35 Arg2:T37	
R37	has-property Arg1:T39 Arg2:T38	
R38	has-property Arg1:T42 Arg2:T41	
R40	is-a Arg1:T39 Arg2:T35	
R41	is-a Arg1:T42 Arg2:T35	
R42	has-property Arg1:T43 Arg2:T44	
R43	in-context Arg1:T43 Arg2:T46	
R44	in-context Arg1:T46 Arg2:T45	
R45	in-context Arg1:T43 Arg2:T35	
T47	Concept 605 613	reported
A2	Negated T47
T48	Concept 619 627	patients
T49	Concept 633 641	COVID-19
T50	Concept 650 662	neurological
T51	Action 663 677	manifestations
T40	Concept 507 513	inbred
A3	Negated T40
R39	has-property Arg1:T42 Arg2:T40	
R46	has-property Arg1:T51 Arg2:T50	
R47	in-context Arg1:T48 Arg2:T49	
R48	in-context Arg1:T51 Arg2:T48	
R49	has-property Arg1:T51 Arg2:T47	
T52	Concept 690 697	numbers
T53	Concept 682 689	average
R50	has-property Arg1:T52 Arg2:T53	
T54	Concept 701 713	CD163+ cells
T55	Concept 718 730	CD163+ cells
T56	Concept 731 741	per villus
T57	Concept 761 767	higher
T58	Concept 775 779	ZIKV
T59	Concept 780 785	group
T60	Concept 787 790	n=5
T61	Concept 813 821	controls
T62	Concept 804 812	negative
A4	Emphasized T57
T63	Concept 823 826	n=3
R51	has-property Arg1:T54 Arg2:T52	
R52	in-context Arg1:T55 Arg2:T56	
R53	has-property Arg1:T55 Arg2:T52	
R54	has-property Arg1:T52 Arg2:T57	
R55	in-context Arg1:T57 Arg2:T59	
R56	has-property Arg1:T59 Arg2:T58	
R57	has-property Arg1:T59 Arg2:T60	
T64	Reference 792 796	than
A5	Negated T64
R58	has-property Arg1:T64 Arg2:T57	
R59	has-property Arg1:T61 Arg2:T62	
R60	in-context Arg1:T61 Arg2:T63	
R61	in-context Arg1:T64 Arg2:T61	
